Researchers Identified New Thioesterase in Burkholderia
The discovery clarifies how B. pseudomallei builds biofilms, potentially exposing a new target for treating melioidosis.
Updated on Oct. 5, 2026 in Life Sciences
Researchers have identified the BPSL0610 protein as a functional thioesterase, revealing its role in the synthesis and modification of exopolysaccharides. This research-stage finding clarifies the previously unknown function of a gene expressed during the formation of biofilms in the pathogen Burkholderia pseudomallei.
Why it matters
Understanding the mechanisms behind biofilm formation in B. pseudomallei is critical for addressing melioidosis, a serious disease caused by the bacterium in humans and animals. This identification resolves an ambiguity in prior genome annotations, providing a clearer target for future therapeutic research.
Computational analysis via AlphaFold2 indicates BPSL0610 is composed of two sequential alpha/beta hydrolase domains, with the C-terminal domain containing a conserved catalytic triad. Recombinant protein assays confirmed catalytic activity against short-chain ester substrates.
The players
Burkholderia pseudomallei
A bacterium responsible for causing melioidosis, characterized by its ability to form protective biofilms.
The details
The team utilized AlphaFold2, an AI system that predicts three-dimensional protein structures from amino acid sequences, to model the architecture of BPSL0610. The protein functions as a thioesterase, a type of enzyme that breaks down thioester bonds, facilitating the modification of exopolysaccharides—complex sugar chains secreted by bacteria. This activity was verified through esterase assays using recombinant protein, confirming its classification under the EC 3.1.1.1 group for carboxylesterases.
Timeline
October 5, 2026: Research article published in Nature.
The Tech Race
This study follows the established pattern of using the AlphaFold2 structural prediction framework to characterize proteins whose functions were previously unknown. It marks a shift from relying solely on sequence similarity toward using predictive protein modeling to identify targets in difficult-to-study pathogens.
This discovery provides researchers with a clearer understanding of biofilm formation, but it remains at the laboratory research stage with no immediate impact on clinical care. Future studies will need to determine if this enzyme can be effectively targeted by small-molecule inhibitors in a therapeutic context.
The takeaway
The identification of BPSL0610 highlights how predictive protein structural modeling is rapidly narrowing the gap in our knowledge of pathogen genomes. Researchers should now look for future studies testing the inhibition of this specific thioesterase in vivo to assess its potential as a drug target.
Further reading
Explore more developments in Life Sciences to understand how structural biology is reshaping infectious disease research.
Source note: This article includes information reported by Nature.
